Navigation Links
Effects of Parkinson's-disease mutation reversed in cells
Date:8/16/2013

ns, the finding that kinetin can speed mutated PINK1 activity to near normal levels raises the possibility that kinetin may be used to treat these patients, Shokat said.

The researchers also found that, in nerve cells with normal PINK1, kinetin boosted enzyme activity beyond typical levels. This finding may be relevant for the most common forms of Parkinsons disease, in which PINK1 is not mutated, because a previous study showed that similar overactivity of PINK1 can slow the development of abnormal movement in a fruit-fly model of Parkinsons disease caused by another defect. This defect is elevated production of the protein alpha-synuclein, also a cause of some inherited cases of Parkinsons disease.

The demonstration in the new study that PINK1 can be boosted in human nerve cells that lack PINK1 mutations therefore suggests that kinetin might also have therapeutic potential in common cases of Parkinsons disease in which PINK1 is not mutated, Shokat said.

Parkinsons disease is the second most common neurodegenerative disease after Alzheimers disease, and the 14th leading cause of death in the United States, according to the U.S Centers for Disease Control and Prevention. Current treatments primarily aim to boost availability of dopamine to brain regions where dopamine-producing nerve cells have been lost.

Although many drugs that inhibit the activity of kinases have been developed over the past decade, including 15 currently approved to treat cancer, Shokat said none has yet been marketed to directly boost activity of a kinase.

The breakthrough in revving up PINK1 activity pharmacologically stemmed from Shokats unconventional approach. He targeted the enzymes substrate, a molecule that binds to an enzyme and undergoes a quick ch
'/>"/>

Contact: Jeffrey Norris
jeff.norris@ucsf.edu
415-502-6397
University of California - San Francisco
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Mirena Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order in New Jersey Mirena Side Effects Litigation
2. Researcher awarded $1.8 million grant to study gender differences in antidepressant effects
3. Mental Health Watchdog Launches Psychiatric Drug Side Effects Database—Search All Drug Regulatory Agency Warnings, Studies & Adverse Reactions Reports
4. Pradaxa Lawsuit Lawyers at Wright & Schulte LLC Disturbed by New Study Finding that Pradaxa Users Face Significantly Higher Risk of Bleeding Side-Effects
5. Research shows negative effects of half-siblings
6. Latest Yaz, Yasmin Lawsuits Alleging Blood-Clotting Side Effects: Resource4thePeople Reports Consolidated Cases Continue to Be Opened, Settled and Dismissed
7. Necrostatin-1 counteracts aluminums neurotoxic effects
8. Understanding the effects of genes on human traits
9. New Update on Alleged Transvaginal Mesh Complications Lawsuits: First Federal Trial Involving Allegations of Serious Side Effects from C.R. Bard Mesh Scheduled to Begin
10. Frequent Urination can be Terminated by Taking Herbal Medicine with No Side Effects, Highlights Wuhan Dr. Lee's TCM Clinic
11. A lifespan-extending drug has limited effects on aging
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... Paul, MN (PRWEB) September 02, 2014 ... been refined and specially formulated, while preserving the foundation ... solutions for hair loss and scalp problems. There is ... on the market today. , Hair loss is a ... ages. Until now, options for treatment have been limited ...
(Date:9/2/2014)... YOUNGSTOWN, Ohio (PRWEB) September 02, 2014 Humility ... at Home, Sept. 18 at St. Elizabeth Health Center, 1044 ... that provides information about more than 200 common health problems ... family, preventing illness and injury, and advice on when to ... 11 a.m. to noon in the Youngstown Room; the evening ...
(Date:9/2/2014)... announce that the following papers will be published ... 2014, taking place in Barcelona, Spain, 30 August ... biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting ... single-blind, non-inferiority trial, Windecker et al , ... polymer, and drug release have improved clinical outcomes ...
(Date:9/2/2014)... Researchers in New Delhi, India have published a paper on ... asbestos-contaminated work clothes for just 3 months as a child. ... a new article. Click here to read it now. ... patient was diagnosed with mesothelioma after complaining of ... come in contact with her miner father’s dirty work clothes ...
(Date:9/2/2014)... Headaches, both chronic and acute ruin lives. They can ... friends, sleeping and just coping well with daily activities. ... worldwide. The medications prescribed for these conditions frequently don’t ... cases of headache and back pain are of a mechanical ... detect and fix the cause. , When a sports ...
Breaking Medicine News(10 mins):Health News:New All Natural, Organic Hair Recovery Products by Moroccan Eco-Biologics, Restore Lost Hair with No Side Effects 2Health News:HMHP Offers ‘Health at Home’ Workshop 2Health News:The Lancet: European Society of Cardiology Congress 2014 media alert 2Health News:New Report Illustrates That Even Brief Asbestos Exposure Can Trigger Mesothelioma, According to Surviving Mesothelioma 2Health News:Physical Therapists in Houston Learn Pain Relief Techniques 2
... 13 Ruth W. Messinger, president of American ... today calling on the international community to actively ... into Darfur so workers can continue providing critical ... displaced persons throughout Darfur and Chad."The already fragile ...
... earning the doctor of optometry degree are encouraged to attend the ... and the N.C. State Education Assistance Authority. Conferences are scheduled ... East ... 10:00 a.m. - 12:00 noon, Tuesday, March 24, 2009 in the ...
... 20th Annual AIDS Walk Houston for Living Positive By DesignHOUSTON, ... series "Project Runway," is visiting Houston for the 20th Annual ... his national HIV and AIDS education initiative. On Sunday, ... helps to support more than 100,000 people with HIV and ...
... million gift for its campaign to build a children,s, ... Mission Bay campus, near downtown San Francisco. This is ... hospital fundraising campaign and among the largest gifts in ... percent match to encourage support from other philanthropists, was ...
... Clinical Care Options (CCO), a leader in education ... information provider, have been named the official providers of ... AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention ... 2009, and the XVIII International AIDS Conference in Vienna, ...
... shift to web news -LITTLE FALLS, N.J., March 13 ... reports on the closing and downsizing of many U.S. ... its list of 10 major daily papers most likely to fold ... New York Times reports that three papers ...
Cached Medicine News:Health News:Optometry Career Conferences Set for Five N.C. Campuses in March 2Health News:'Project Runway' Designer in Houston to Educate About Living With HIV and Combat Stigma Associated With the Disease 2Health News:'Project Runway' Designer in Houston to Educate About Living With HIV and Combat Stigma Associated With the Disease 3Health News:UCSF Medical Center receives $125 million gift to build new hospital 2Health News:UCSF Medical Center receives $125 million gift to build new hospital 3Health News:UCSF Medical Center receives $125 million gift to build new hospital 4Health News:Clinical Care Options and NAM Selected by the International AIDS Society to Collaborate on Official Online Conference Coverage From Annual Meetings 2Health News:Clinical Care Options and NAM Selected by the International AIDS Society to Collaborate on Official Online Conference Coverage From Annual Meetings 3Health News:Print Media Under Siege - Are Readers Disappearing? 2
(Date:9/2/2014)... 2014  Boston Scientific Corporation (NYSE: ... to purchase the Interventional business of Bayer AG. ... to offer physicians and healthcare systems a more ... conditions. The addition of the Bayer ... the Boston Scientific strategy to provide a comprehensive ...
(Date:9/2/2014)... , Sept. 2, 2014  Based on its ... device market, Frost & Sullivan recognizes Novian Health, ... Sullivan Award for Technology Innovation Leadership. Novian Health ... and malignant tumors with its proprietary technology, Novilase ... a reliable, accurate, and easy-to-control ultrasound-guided thermo ablation ...
(Date:9/2/2014)... 2014  Abaxis, Inc. (NasdaqGS: ABAX ), ... consumables to the medical, research and veterinary markets, announced ... Executive Officer, will present at the Morgan Stanley Global ... a.m. ET. The conference will be held at the ... City . About Abaxis Abaxis develops, ...
Breaking Medicine Technology:Boston Scientific Closes Acquisition Of Interventional Business Of Bayer AG 2Boston Scientific Closes Acquisition Of Interventional Business Of Bayer AG 3Boston Scientific Closes Acquisition Of Interventional Business Of Bayer AG 4Boston Scientific Closes Acquisition Of Interventional Business Of Bayer AG 5Novian Health Wins Acclaim from Frost & Sullivan for Novilase Interstitial Laser Ablation Therapy for Early-Stage Malignant Breast Tumors 2Novian Health Wins Acclaim from Frost & Sullivan for Novilase Interstitial Laser Ablation Therapy for Early-Stage Malignant Breast Tumors 3Novian Health Wins Acclaim from Frost & Sullivan for Novilase Interstitial Laser Ablation Therapy for Early-Stage Malignant Breast Tumors 4Novian Health Wins Acclaim from Frost & Sullivan for Novilase Interstitial Laser Ablation Therapy for Early-Stage Malignant Breast Tumors 5Abaxis, Inc. to Present at the Morgan Stanley Global Healthcare Conference 2
... 1 Clinicians at Institut Catala d,Oncologia (ICO) in Barcelona ... RapidArc® radiotherapy from Varian Medical Systems (NYSE: VAR). A 73-year-old prostate cancer ... country to receive the fast and efficient treatment. , ... "The treatment went very well and the patient ...
... SAN DIEGO , June 1, 2010 Amylin Pharmaceuticals, ... , MD has been appointed Senior Vice President, Research and Development. ... Chief Medical Officer. These leadership changes will strengthen the Company,s focus ... its late-stage development programs, both important value drivers for the Company. ...
Cached Medicine Technology:Prostate Cancer Patient First in Spain to Receive Fast and Precise RapidArc(R) Radiotherapy Treatment from Varian 2Prostate Cancer Patient First in Spain to Receive Fast and Precise RapidArc(R) Radiotherapy Treatment from Varian 3Prostate Cancer Patient First in Spain to Receive Fast and Precise RapidArc(R) Radiotherapy Treatment from Varian 4Amylin Pharmaceuticals Appoints Christian Weyer, MD Senior Vice President, Research and Development 2Amylin Pharmaceuticals Appoints Christian Weyer, MD Senior Vice President, Research and Development 3Amylin Pharmaceuticals Appoints Christian Weyer, MD Senior Vice President, Research and Development 4Amylin Pharmaceuticals Appoints Christian Weyer, MD Senior Vice President, Research and Development 5
Liquichek Whole Blood Volatiles Control is an assayed liquid control for monitoring volatile compounds. This product is available in 2 levels....
qUAntify Control is designed to monitor the performance of urine dipstick testing. The control is available in 12 mL ready-to-use dropper bottles....
Lyphochek Urine Bone Markers Control is a bilevel human urine based control designed to monitor tests for urinary markers of osteoporosis management and bone resorption....
Lyphochek Tumor Marker Control is a comprehensive, bilevel product designed to assess the performance of various cancer antigen tests, including esoteric tumor markers....
Medicine Products: